10 Worst-Performing Growth Stocks in 2024
Economists anticipate modest US economic growth in the upcoming quarters, and some continue to caution that a mild recession could occur.
Acadia Pharmaceuticals Inc (ACAD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 42,877,916 | $696,766,135 | +1% | 8.9% |
| 2. | Point72 Asset Management Steve Cohen | 3,710,140 | $60,289,775 | +378% | 0.15% |
| 3. | Millennium Management Israel Englander | 2,937,714 | $47,737,852 | +40% | 0.02% |
| 4. | D E Shaw D. E. Shaw | 2,934,926 | $47,692,548 | +12% | 0.04% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,774,353 | $45,083,239 | +432% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 259,109 | Large Shareholder, Director | 39,317,673 | 2023-05-24 | Filing | |
| $25.65 | 24,113 | Large Shareholder, Director | 3,610,443 | 2023-05-24 | Filing | |
| $25.51 | 28,878 | Large Shareholder, Director | 39,058,564 | 2023-05-24 | Filing | |
| $25.51 | 2,688 | Large Shareholder, Director | 3,586,330 | 2023-05-24 | Filing | |
| $25.27 | 218,171 | Large Shareholder, Director | 39,029,686 | 2023-05-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.28 | 9,733 | 43,735 | 2024-08-19 | Filing | ||
| $15.28 | 9,534 | 52,177 | 2024-08-19 | Filing | ||
| $15.28 | 31,747 | 186,555 | 2024-08-19 | Filing | ||
| $14.79 | 975 | 34,564 | 2024-06-10 | Filing | ||
| $16.94 | 3,503 | 32,053 | 2024-05-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,396,009 | $419,429,041 | 0% | |
| 2. | 11,410,483 | $357,262,222 | 0% | |
| 3. | 11,253,551 | $352,348,682 | 5.5% | |
| 4. | 6,465,026 | $202,419,964 | 0% | |
| 5. | 5,265,358 | $164,858,357 | 0.01% |
News See All
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals Second Quarter 2024 Financial Results Conference Call.
7 Best Halal Stocks To Buy Now (Debt Free)
Islamic equity investing, also known as Halal investing, has gained significant traction recently as Muslim investors seek to align their financial decisions with their religious beliefs.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals First Quarter 2024 Financial Results and Operating Overview Conference Call.
5 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.
Billionaire Steve Cohen and Insiders are Buying These 5 Stocks
This article presents an overview of Billionaire Steve Cohen and Insiders are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Billionaire Steve Cohen and Insiders ...
5 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.
5 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold NASDAQ stocks to buy right now.
5 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold healthcare stocks to buy right now.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc.
Billionaire Hedge Funds
